Does carbapenem-resistant enterobacteriaceae infection drive venous thromboembolism in patients admitted to intensive care units receiving prophylactic anticoagulants? :Fahad A S. Aleidan, Sara Albilal, Maha Alammari, Khalid Al Sulaiman, Mohammed Alassiri, Abdel Galil Abdel Gadir, Journal of Applied Hematology

ORIGINAL ARTICLE
Year : 2022 | Volume : 13 | Issue : 3 | Page : 139--144

Does carbapenem-resistant enterobacteriaceae infection drive venous thromboembolism in patients admitted to intensive care units receiving prophylactic anticoagulants?

Fahad A S. Aleidan¹, Sara Albilal², Maha Alammari², Khalid Al Sulaiman², Mohammed Alassiri³, Abdel Galil Abdel Gadir¹
¹ Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
² Department of Pharmaceutical Care, King Abdulaziz Medical City; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
³ King Abdullah International Medical Research Center; Department of Basic Sciences, College of Science and Health Professions, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia

Correspondence Address:
Prof. Fahad A S. Aleidan
Department of Basic Medical Sciences, College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Riyadh
Saudi Arabia

BACKGROUND: Systemic infections are one of several risk factors leading to the development of inflammation and venous thromboembolism (VTE) formation. This study aimed to assess the risk factors associated with the development of VTE in patients admitted to the intensive care unit (ICU). MATERIALS AND METHODS: A retrospective-matched case − control study of patients with VTE in the period between January 1, 2018, and December 31, 2019. We included all adult patients who stayed more than 2 days in ICU before the development of VTE. RESULTS: Univariate and multivariate analyses uncovered three of six factors to have significant influence in the development of VTE in ICU patients: Carbapenem-resistant Enterobactereaceae (CRE) infections (odds ratio [OR] 2.95, 95% confidence interval (CI) 1.21–7.33, P = 0.010), length of ICU stay (OR 1.02, 95% CI 1.01–1.04, P = 0.011), and the sequential organ failure assessment score (OR 1.10, 95% CI 1.01–1.20, P = 0.031); all were found to be independent risk factors in the development of VTE. CONCLUSION: Our findings suggest that, CRE infection is a strong trigger to the development of VTE in patients admitted to the ICU, and draw the attention of the treating clinicians to prioritize these infections in the management protocols to control infection-driven VTE in ICU patients.

How to cite this article:
S. Aleidan FA, Albilal S, Alammari M, Al Sulaiman K, Alassiri M, Abdel Gadir AG. Does carbapenem-resistant enterobacteriaceae infection drive venous thromboembolism in patients admitted to intensive care units receiving prophylactic anticoagulants?.J Appl Hematol 2022;13:139-144

How to cite this URL:
S. Aleidan FA, Albilal S, Alammari M, Al Sulaiman K, Alassiri M, Abdel Gadir AG. Does carbapenem-resistant enterobacteriaceae infection drive venous thromboembolism in patients admitted to intensive care units receiving prophylactic anticoagulants?. J Appl Hematol [serial online] 2022 [cited 2023 Sep 22 ];13:139-144
Available from: https://www.jahjournal.org/article.asp?issn=1658-5127;year=2022;volume=13;issue=3;spage=139;epage=144;aulast=S.;type=0